InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（6 笔）
内部人交易记录
其他已披露买入
5
已披露卖出
6
T+90 胜率
0%
T+90 平均收益
-19.6%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Bain Capital Life Sciences Investors, LLC. Insider active across 10 companies, notably Rapid Micro Biosystems, INC.. Cumulatively, 17 reports have been logged. Split: 5 buys · 6 sells. Total volume traded: €185.2m. History available since 10 August 2021. The latest transaction was disclosed on 30 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bain Capital Life Sciences Investors, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
892,533 股@ US$29.181.05% mcap44.1% 占其流量Common StockSEC:0001193125-26-198593:2
254,110 股@ US$30.510.31% mcap13.2% 占其流量Common StockSEC:0001193125-26-198593:0
797,133 股@ US$29.370.95% mcap39.8% 占其流量Common StockSEC:0001193125-26-198593:1
56,224 股@ US$30.050.068% mcap2.9% 占其流量Common StockSEC:0001193125-26-198593:3
1,562,500 股@ US$16.00100.0% 占其流量Common StockSEC:0001193125-26-164389:2
标准退出：2026年7月19日 (T+90)
16,875,000 股Common StockSEC:0001193125-26-164389:0
4,145,768 股Common StockSEC:0001193125-26-164389:1
2,000,000 股@ US$28.0548.6% 占其流量Common StockSEC:0001193125-26-041349:0
12,014,234 股Common StockSEC:0000950170-25-107981:0
1,000,000 股@ US$4.0345.8% 占其流量Common StockSEC:0000950170-25-025011:0
标准退出：2025年5月20日 (T+90)
300,000 股@ US$5.7579100.0% 占其流量Common StockSEC:0000950170-25-004870:0
标准退出：2025年4月8日 (T+90)
2,713,868 股Common StockSEC:0000950170-24-015358:0
904,160 股@ US$5.5354.2% 占其流量Common StockSEC:0000950170-24-004289:0
300,000 股@ US$2.1324100.0% 占其流量Common StockSEC:0000899243-23-014139:0
标准退出：2023年8月23日 (T+90)
13,458 股@ US$9.6206100.0% 占其流量Common StockSEC:0000899243-21-047829:0
标准退出：2022年3月8日 (T+90)
1,000,000 股@ US$70.25100.0% 占其流量Common StockSEC:0000899243-21-032893:0
6,999,998 股Class A Common StockSEC:0000899243-21-029222:0
17 条申报中的 17 条
About Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC is a declarant, 10% Owner of Heartflow, Inc. and Kailera Therapeutics, Inc. It has made 17 filings, and across the recent sample of 17 filings, the amounts shown run from 2021-07-21 to 2026-04-30, with buys of EUR 27452573 and sells of EUR 157698434, and the modal transaction nature is Sale.
